Business Intelligence on Healthcare Market Research

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT. Based on application

In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements. The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.  On the basis of accessories and consumables, the market is segmented into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is expected to be the fastest-growing of the global gas chromatography market during the foreca

The global high-content screening (HCS) market is consolidated in nature with the top five players commanding a major share of the market. GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) lead the global market. Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.). The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.  Danaher Corporation holds a leading position in the market. The company designs, manufactures, and markets professional, medical, industrial, and commercial products & services. Danaher Corporation primarily focuses on product launches as its key business strategy. For example, in February 2017, Molecular Devi

The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period. The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. Key players in the market focus on partnerships, collaborations, and agreements; product launches, expansions; and acquisitions to strengthen their posit

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.). The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%. The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).

Thermo Fisher Scientific Inc. is one of the top players in the market. The company operates in more than 180 countries across North America, Europe, Asia, and Latin America. It offers HCS instruments and software among other products. The company focuses on product launches as its key business strategy. In May 2016, the company launched the Invitrogen Evos FL Auto 2 Imaging System to provide rapid capture and analysis of higher-quality images in live-cell imaging experiments. In addition, in January 2016, Thermo Fisher Scientific launched the Cell Insight CX7 high-content analysis platform. This strengthened the company’s hold in the HCS market. The  " High Content Screening Market  is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%. The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS

The factors expected to drive the growth of the market are growth in funding for cellular research, cost containment in pharma R&D, and technological advancements in HCS solutions. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth. The global high-content screening market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The market is segmented based on product, application, end user, and region. Based on product, the market is segmented into instruments, consumables, software, services, and accessories. Based on application, the market is segmented into target identification and validation, primary and secondary screening, toxicity studies, compound profiling, and other applic

This report segments the market based on type, application, and region. On the basis of type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. However, the collaborative pharmaceutical robots segment is expected to register the highest CAGR of 36.6% during the forecast period. The ability to operate collaboratively with humans as well as their ability to be re-deployed easily is contributing to their growth during the forecast period. The pharmaceutical robots market is projected to reach USD 119.5 million by 2021 from USD 64.4 million in 2016, at a CAGR of 13.2%. On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such

According to the new market research report “ Pharmacy Automation System Market  by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022 " , published by MarketsandMarkets™, The global pharmacy automation market is projected to reach USD 5.38 billion by 2022, at a CAGR of 8.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs. Pharmacy automation systems refer to a variety of systems and software designed to increase the productivity of pharmacies and precision of the medication compounding process by reducing human intervention. Automated systems mechanize various procedures in pharmacies, including the storage, packaging, dispensing

New market research report " Gas Chromatography Market  by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators),End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) - Global Forecast to 2022" , published by MarketsandMarkets™, The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%. The gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements. On the basis of accessories and consumables, the mark

The global pharmaceutical robots market is segmented on the basis of type, application, and region. The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021. This market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016. On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging

In this report, the market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets. The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022. The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, HCS solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed market

In this report is segmented on the basis of product, method, application, end user, and region. Based on product, the market is segmented into consumables and instruments. The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016 at a CAGR of 16.4% during the forecast period.  Based on application, the market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities. Based on end user, the NIPT market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and initiatives by companies to provide technological

In this research study involves the extensive use of secondary sources, directories, and databases, such as World Health Organization, Food and Drug Administration, the World Bank, Organisation for Economic Co-operation and Development (OECD), and the International Society of Plastic Surgery (ISAPS), to identify and collect information useful for this technical, market-oriented, and financial study of the medical aesthetics market. The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 9.42 billion in 2017, at a CAGR of 10.6% during the forecast period.  The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of this market. The Medical Aesthetics

Factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market. The global  high-content screening market  is expected to reach USD 909.0 million by 2022 from USD 557.1 million in 2017, at a CAGR of 10.3%. The market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets. In 2016, the instruments segment accounted for the largest share in the HCS market. The l

This Market Research report aims to provide insights into the global market. It provides valuable information on anatomic pathology product & service and application. Details on regional Anatomical pathology markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. The  anatomic pathology market  is expected to reach USD 21.9 billion by 2021 from USD 16.2 billion in 2016, at a CAGR of 6.1%. Market report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates & forecasts and market share analysis. The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infe

The market for  filter integrity test Market  is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period. The growth of the global filter integrity test market is mainly driven by the increasing R&D spending across the globe, growth in the biopharmaceutical industry, and increasing purity requirements. The liquid filter integrity test segment accounted for the largest share of the global filter integrity test market in 2018. On the basis of filter type, the filter integrity test market is segmented into liquid and air filter integrity tests. The liquid filter integrity test segment accounted for the largest market share in 2018. The liquid filter integrity test method includes bubble point and diffusive flow tests. This testing method is correlated to a liquid bacteria challenge test, and the correlation verifies the integrity test limits the filters have to pass. Liquid integrity tests can be used on both hydrophobi

The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of this market. On the other hand, market growth is limited to a certain extent by factors such as the clinical risks and complications associated with medical aesthetic procedures and the increasing availability and adoption of alternative beauty and cosmetic products. The global  medical aesthetics market  is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.  This market is segmented into facial aesthetic products (dermal fillers, botulinum toxin, microdermabrasion, and chemical peels); body contouring devices (nonsurgical fat reduction devices, cellulite reduction devices, and lipo

In this report, the US anticoagulation therapy market is segmented on the basis of products and clinics. On the basis of products, the market is segmented into anticoagulation drugs and PT/INR testing devices. The  US anticoagulation therapy market  is projected to reach USD 27.83 Billion by 2022 from an estimated USD 18.49 Billion in 2017, at a CAGR of 8.5%.  Market growth is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs). The anticoagulation therapy market for drugs is segmented into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment dominated the US anticoagulation therapy market for drugs. Due to the better safety and efficacy of NOACs as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key

Gas chromatography is an analytical separation technique used to analyze volatile substances and separate organic compounds in the gas phase. By separating the sample into individual components, GC allows to identify (qualitative) and measure the amount (quantitative) of the various sample components. These measurements of organic compounds allow applications in petrochemical and pharmaceuticals, environmental measurements of aromatic pollutants in air and water, and in the detection and measurement of pesticides, among others. Accoring to marketsandmarkets  gas chromatography market  is expected to reach USD 3.67 billion by 2022 from USD 2.64 billion in 2016, at a CAGR of 6.2%. Increase in crude & shale oil production, increasing importance of waste water treatment, rising adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns, and increased importance of chromatography in drug testing are the key factors driving the growth of thi

The medical connectors market is projected to reach USD 2.69 billion by 2021 from USD 1.63 billion in 2016, at a CAGR of 10.5%. Globally, the market is witnessing moderate growth due to factors such as growth in the medical devices market and the growing home healthcare market that is resulting in the increasing demand for miniaturized connectors and increasing healthcare expenditure. However, the stringent regulatory standards are a major factor restraining the growth of this market. The  medical connectors market  is segmented based on products, application, end user, and region in this report. On the basis of products, the market is segmented into flat surgical silicone cables, embedded electronics connectors, radio-frequency connectors, disposable plastic connectors, hybrid circular connectors & receptacle system, power cords with retention system, lighted hospital-grade cords, magnetic medical connectors, and push-pull connectors. The flat surgical silicone cables segmen

The global pharmacy automation market is projected to reach USD 5.38 billion by 2022, at a CAGR of 8.2% from 2017 to 2022.  The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs. Pharmacy automation systems refer to a variety of systems and software designed to increase the productivity of pharmacies and precision of the medication compounding process by reducing human intervention. Automated systems mechanize various procedures in pharmacies, including the storage, packaging, dispensing, pickup, delivery, and distribution of drugs. The  pharmacy automation market  has been segmented on the basis of product, into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy a

The growth of the market is attributed to factors such as cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The global  high-content screening market  is expected to reach USD 909.0 million by 2022 from USD 557.1 million in 2017, at a CAGR of 10.3%. The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market. Know More Details @  https://www.marketsandmarkets.com/Market-Reports/high-content

The  non-invasive prenatal testing market  is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period. The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into cons

The  glycomics/glycobiology  market across the globe is witnessing high growth. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market. The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth. On the other hand, high degree of consolidation hinders entry of new players to the market and stringent regulatory frameworks and time-consuming approval processes are restraining the gro